Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes
Eric E. Smith(University of Calgary), Thomas Töll(Population Health Research Institute), Teruyuki Hirano(The Graduate University for Advanced Studies, SOKENDAI), Laura Heenan(Population Health Research Institute), Darshan Ghia(Fiona Stanley Hospital), Geoffrey Cloud(Monash University), Ramesh Sahathevan(St Vincent's Hospital Melbourne), Jaime Masjuán(Universidad de Alcalá), Pablo Colorado, Robin Lemmens(VIB-KU Leuven Center for Microbiology), Valeria Caso, A. Langer, Timothy Kleinig(Royal Adelaide Hospital), Jean‐Louis Mas(Centre Hospitalier Sainte-Anne), Hardi Mundl(Roche (Switzerland)), Chiu‐Yin Kwan(Population Health Research Institute), Maurício Krause(Universidade Federal do Rio Grande do Sul), Matthias Vigl(Bayer (Germany)), Benjamin Dejakum(Population Health Research Institute), Ashkan Shoamanesh(Population Health Research Institute), Andrew Chew, Michael J. Devlin(Princess Alexandra Hospital), Martha Marko(McMaster University), Philip Choi, Chih‐Hao Chen(University of Calgary), Carlos García-Esperón, Sophia J. Kiechl(Population Health Research Institute), Feryal Saad(University of Calgary), Henry G. Brown(Population Health Research Institute), Jéssica Tonin Ferrari(Population Health Research Institute), Miriam Priglinger(The University of Sydney), Jakob Rath(Population Health Research Institute), Gian Marco De Marchis(University of St.Gallen), Bruce Campbell(The Royal Melbourne Hospital), Stuart J. Connolly(Population Health Research Institute), Ivan Milanov(Vita-Salute San Raffaele University), Peter Bailey(Gold Coast Hospital), Alexandra Bernegger, Robert G. Hart(University of British Columbia), Dennis Cordato(Liverpool Hospital), Vimal Stanislaus(The Royal Melbourne Hospital), Stefan Greisenegger(Ludwig Boltzmann Institute Applied Diagnostics), M. Baumgartinger(Bayer (Germany)), Stefan Krebs(Population Health Research Institute), Lizhen Xu(Hospital for Sick Children), S. Bonelli-Nauer(Population Health Research Institute), Rohan Grimley(MACOM (United States)), W. Lang, M. Knoflach(Bayer (Germany))
Cited by 10
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k